Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: A pilot project-Reference-Cited by-同舟云学术

Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: A pilot project

Published:2008-08 Issue:8 Volume:43 Page:753-759
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr. Pulmonol.

Author:

Coates Allan L,Green Maria,Leung Kitty,Chan Jeffrey,Ribeiro Nancy,Louca Emily,Ratjen Felix,Charron Martin,Tservistas Markus,Keller Manfred

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference38 articles.

1. Safety and efficacy of tobramycin solution for inhalation in patients with cystic fibrosis: the results of two Phase III placebo controlled clinical trials;Ramsey;Pediatr Pulmonol,1997

2. Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa;MacLusky;Pediatr Pulmonol,1989

3. Significant microbiological effects of inhaled tobramycin in young children with cystic fibrosis;Gibson;Am J Respir Crit Care Med,2003

4. A randomized clinical trial of nebulised tobramycin or colistin in cystic fibrosis;Hodson;Eur Respir J,2003

5. Ways of coping with cystic fibrosis: implications for treatment adherence;Abbott;Disabil Rehabil,2001

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review;Journal of Clinical Medicine;2023-05-20

2. Nuclear medicine imaging methods as novel tools in the assessment of pulmonary drug disposition;Expert Opinion on Drug Delivery;2022-10-27

3. Indian Guidelines on Nebulization Therapy;Indian Journal of Tuberculosis;2022

4. Status of inhalable antimicrobial agents for lung infection: progress and prospects;Expert Review of Respiratory Medicine;2021-05-04

5. Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy;Advanced Drug Delivery Reviews;2021-02